Cargando…

PD-L1 Testing in Urothelial Carcinoma: Analysis of a Series of 1401 Cases Using Both the 22C3 and SP142 Assays

Immune checkpoint blockade (ICB) drugs are a novel, effective treatment for advanced urothelial carcinoma. Worldwide, several different ICB drugs are approved, each developed and clinically validated with a specific PD-L1 compound diagnostic assay. As a result, PD-L1 testing workflows in routine pra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evans, Harriet, O’Sullivan, Brendan, Hughes, Frances, Charles, Kathryn, Robertson, Lee, Taniere, Philippe, Diaz-Cano, Salvador
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036367/ https://www.ncbi.nlm.nih.gov/pubmed/35478498 http://dx.doi.org/10.3389/pore.2022.1610260

Ejemplares similares

Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2022)

Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2023)

High prevalence of Wilms tumor 1 expression in multiple myeloma and plasmacytoma: A cohort of 142 Asian patients’ samples
por: Phikulsod, Ployploen, et al.
Publicado: (2023)

PD-1 and PD-L1 expression in rare lung tumors
por: Gyulai, Marton, et al.
Publicado: (2023)

Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus
por: Király, Zsófia, et al.
Publicado: (2022)

Case report: Urothelial carcinoma of the renal pelvis with trophoblastic differentiation: A rare case report and review of literature
por: Wang, Zhuo, et al.
Publicado: (2023)

Prevalence and Prognostic Implications of PD-L1 Expression in Soft Tissue Sarcomas
por: Kelany, Mohamed, et al.
Publicado: (2021)

Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
por: Forika, Gertrud, et al.
Publicado: (2021)

Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy
por: Pfaendler, Krista S, et al.
Publicado: (2022)

Intracystic endometrioid borderline tumor
por: El Hajj, Houssein, et al.
Publicado: (2023)

Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients
por: Horesh, Adi, et al.
Publicado: (2023)

Solitary Calvarial Metastasis As the First Presentation of Urothelial Bladder Cancer
por: Bistazzoni, Simona, et al.
Publicado: (2021)

Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma—A Large Multi-Institutional International Study
por: Zaakouk, Mohamed, et al.
Publicado: (2023)

Role of Cytokeratin 20 as a Predictive and Prognostic Marker in Urothelial Neoplasms
por: Popov, Hristo, et al.
Publicado: (2022)

Fibroblast Growth Factor-2 and the Invasive Potential in Urothelial Malignancies of the Bladder
por: Popov, Hristo, et al.
Publicado: (2023)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

Sarcomatoid Urothelial Carcinoma With Myxoid Stroma: A Case Report and Diagnostic Approach
por: Taseer, Rabia, et al.
Publicado: (2021)

Overexpression of Her-2 in Biopsy-Proven Urothelial Carcinoma Patients From Pakistan
por: Chughtai, Anila, et al.
Publicado: (2022)

Role of GATA3 in Early-Stage Urothelial Bladder Carcinoma Local Recurrence
por: Popov, Hristo, et al.
Publicado: (2023)

Correlation of HER2 With p53 and p63 in Urothelial Bladder Carcinoma
por: Ponnaboina, Divya Madhuri, et al.
Publicado: (2023)

Differentiation of Urothelial Carcinoma into Two Distinct Subtypes, Glandular and Squamous, in Three Different Organs
por: El-Asmar, Jose M, et al.
Publicado: (2020)

Androgen Receptor: Evaluation and Correlation with Recurrence and Clinicopathological Parameters in Papillary Urothelial Carcinomas of the Urinary Bladder
por: Mumtaz, Shazia, et al.
Publicado: (2020)

Tumour Behaviour of Low-Grade Papillary Urothelial Carcinoma: A Single-Centre Retrospective Study
por: Dutta, Satya, et al.
Publicado: (2021)

Urothelial Papilloma of the Urinary Bladder: A Case Report and Literature Review of a Rare Entity
por: Abdel Gawad, Ahmed M, et al.
Publicado: (2022)

Metastatic Plasmacytoid Urothelial Carcinoma Masquerading as a Primary Signet Ring Cell Carcinoma of the Duodenum
por: Mir, Adil S, et al.
Publicado: (2023)

Renal Oncocytoma and Pelvic Urothelial Carcinoma in a Nephrectomy Specimen of a 72-Year-Old Patient
por: Atique, Usman, et al.
Publicado: (2023)

Sarcomatoid Urothelial Carcinoma of the Urinary Bladder With Chondrosarcomatous and Concurrent Divergent Squamous Cell Carcinoma Differentiation– A Rare Entity
por: Kumar Pal, Atanu, et al.
Publicado: (2022)

Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy
por: Tian, Xi, et al.
Publicado: (2021)

Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden
por: Ma, Weijun, et al.
Publicado: (2021)

Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016
por: Gálffy, Gabriella, et al.
Publicado: (2021)

Low Expression of Stanniocalcin 1 (STC-1) Protein Is Associated With Poor Clinicopathologic Features of Endometrial Cancer
por: Khatun, Masuma, et al.
Publicado: (2021)

Clinical Value of TXNDC12 Combined With IDH and 1p19q as Biomarkers for Prognosis of Glioma
por: Wang, Xinzhuang, et al.
Publicado: (2021)

Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor
por: Radeczky, Peter, et al.
Publicado: (2021)

Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Advanced Biliary Tract Cancer
por: Chen, Chen, et al.
Publicado: (2021)

Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma
por: Jiang, Xili, et al.
Publicado: (2021)

Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients
por: Cai, Hai, et al.
Publicado: (2021)

Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features
por: Turkevi-Nagy, Sándor, et al.
Publicado: (2021)

Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC
por: Zheng, Hongmei, et al.
Publicado: (2021)

Expression of TSP50, SERCA2 and IL-8 in Colorectal Adenoma and Carcinoma: Correlation to Clinicopathological Factors
por: Youssef, Heba M. K., et al.
Publicado: (2021)

GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study
por: Jain, Deepali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_glotk7en2oglcf4a3toqr92g9b